We are testing a new treatment for patients with active ANCA-associated vasculitis to see if it helps achieve lasting remission compared to standard care. The study will also evaluate its impact on disease relapse and kidney health.
Health conditions and diseases that the clinical trial is designed to study and treat.
Microscopic Polyangiitis (MPA) is a type of autoimmune disease that causes inflammation of small blood vessels, leading to damage in organs such as the kidneys and lungs. It is often associated with the presence of specific antibodies called ANCA.
Granulomatosis with Polyangiitis (GPA) is an autoimmune condition characterized by inflammation of blood vessels and the formation of granulomas, which can affect various organs, particularly the lungs and kidneys.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
